News | July 06, 2022
Wacker to expand mRNA-based actives capacity at Halle, Germany
Company is investing more than €100 million in the expansion of the Halle site
Company is investing more than €100 million in the expansion of the Halle site
The AICVD tool can predict the risk of cardiovascular disease.
This multicenter, open-label Phase I study is designed to assess the safety and tolerability
A newly revealed mechanism by Weizmann Institute of Science of ketamine’s action on potassium channels in neurons may lead to improved therapies for depression
Condon joins DTx Pharma with more than 20 years of experience in business development, commercial planning, and operations.
The Congress was held on June, 20-21, 2022 in Berlin, Germany
Dr. Rizo brings extensive industry leadership experience to Vividion, having held multiple senior executive roles during her career at both biotechnology and large pharmaceutical companies.
Brings 25 years of global operations and supply chain experience to Piramal
COR803 is a novel small molecule 3CLpro inhibitor discovered and developed by Cortexyme based on its expertise in cysteine protease inhibition.
Bioresource Technology's state of the art manufacturing facility in Weston, Florida
Subscribe To Our Newsletter & Stay Updated
